Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation

Aromatase inhibitors are used to treat oestrogen receptor positive breast cancers but the molecular basis for the response of patients is unclear. Here, the authors use samples from an aromatase inhibitor clinical trial and show that tumours from poor responders have more mutations than good respond...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pascal Gellert, Corrinne V. Segal, Qiong Gao, Elena López-Knowles, Lesley-Ann Martin, Andrew Dodson, Tiandao Li, Christopher A. Miller, Charles Lu, Elaine R. Mardis, Alexa Gillman, James Morden, Manuela Graf, Kally Sidhu, Abigail Evans, Michael Shere, Christopher Holcombe, Stuart A. McIntosh, Nigel Bundred, Anthony Skene, William Maxwell, John Robertson, Judith M. Bliss, Ian Smith, Mitch Dowsett, POETIC Trial Management Group and Trialists
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/555df6a99ecd4105b13f149fab06246c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:555df6a99ecd4105b13f149fab06246c
record_format dspace
spelling oai:doaj.org-article:555df6a99ecd4105b13f149fab06246c2021-12-02T15:34:56ZImpact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation10.1038/ncomms132942041-1723https://doaj.org/article/555df6a99ecd4105b13f149fab06246c2016-11-01T00:00:00Zhttps://doi.org/10.1038/ncomms13294https://doaj.org/toc/2041-1723Aromatase inhibitors are used to treat oestrogen receptor positive breast cancers but the molecular basis for the response of patients is unclear. Here, the authors use samples from an aromatase inhibitor clinical trial and show that tumours from poor responders have more mutations than good responders and also more frequently harbour p53 mutations.Pascal GellertCorrinne V. SegalQiong GaoElena López-KnowlesLesley-Ann MartinAndrew DodsonTiandao LiChristopher A. MillerCharles LuElaine R. MardisAlexa GillmanJames MordenManuela GrafKally SidhuAbigail EvansMichael ShereChristopher HolcombeStuart A. McIntoshNigel BundredAnthony SkeneWilliam MaxwellJohn RobertsonJudith M. BlissIan SmithMitch DowsettPOETIC Trial Management Group and TrialistsNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-11 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Pascal Gellert
Corrinne V. Segal
Qiong Gao
Elena López-Knowles
Lesley-Ann Martin
Andrew Dodson
Tiandao Li
Christopher A. Miller
Charles Lu
Elaine R. Mardis
Alexa Gillman
James Morden
Manuela Graf
Kally Sidhu
Abigail Evans
Michael Shere
Christopher Holcombe
Stuart A. McIntosh
Nigel Bundred
Anthony Skene
William Maxwell
John Robertson
Judith M. Bliss
Ian Smith
Mitch Dowsett
POETIC Trial Management Group and Trialists
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
description Aromatase inhibitors are used to treat oestrogen receptor positive breast cancers but the molecular basis for the response of patients is unclear. Here, the authors use samples from an aromatase inhibitor clinical trial and show that tumours from poor responders have more mutations than good responders and also more frequently harbour p53 mutations.
format article
author Pascal Gellert
Corrinne V. Segal
Qiong Gao
Elena López-Knowles
Lesley-Ann Martin
Andrew Dodson
Tiandao Li
Christopher A. Miller
Charles Lu
Elaine R. Mardis
Alexa Gillman
James Morden
Manuela Graf
Kally Sidhu
Abigail Evans
Michael Shere
Christopher Holcombe
Stuart A. McIntosh
Nigel Bundred
Anthony Skene
William Maxwell
John Robertson
Judith M. Bliss
Ian Smith
Mitch Dowsett
POETIC Trial Management Group and Trialists
author_facet Pascal Gellert
Corrinne V. Segal
Qiong Gao
Elena López-Knowles
Lesley-Ann Martin
Andrew Dodson
Tiandao Li
Christopher A. Miller
Charles Lu
Elaine R. Mardis
Alexa Gillman
James Morden
Manuela Graf
Kally Sidhu
Abigail Evans
Michael Shere
Christopher Holcombe
Stuart A. McIntosh
Nigel Bundred
Anthony Skene
William Maxwell
John Robertson
Judith M. Bliss
Ian Smith
Mitch Dowsett
POETIC Trial Management Group and Trialists
author_sort Pascal Gellert
title Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
title_short Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
title_full Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
title_fullStr Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
title_full_unstemmed Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
title_sort impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/555df6a99ecd4105b13f149fab06246c
work_keys_str_mv AT pascalgellert impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT corrinnevsegal impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT qionggao impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT elenalopezknowles impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT lesleyannmartin impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT andrewdodson impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT tiandaoli impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT christopheramiller impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT charleslu impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT elainermardis impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT alexagillman impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT jamesmorden impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT manuelagraf impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT kallysidhu impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT abigailevans impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT michaelshere impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT christopherholcombe impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT stuartamcintosh impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT nigelbundred impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT anthonyskene impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT williammaxwell impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT johnrobertson impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT judithmbliss impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT iansmith impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT mitchdowsett impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
AT poetictrialmanagementgroupandtrialists impactofmutationalprofilesonresponseofprimaryoestrogenreceptorpositivebreastcancerstooestrogendeprivation
_version_ 1718386718740054016